AIM ImmunoTech Inc. · AMEX:AIM

Equels Thomas K bought 20,000 AIM ImmunoTech Inc. shares (Form 4)

Traded Nov 18, 2026 · Filed Nov 18, 2026

On Nov 18, 2026, Equels Thomas K (Director, CEO & President) bought 20,000 AIM ImmunoTech Inc. shares at US$0.13 for US$2,680, leaving 386,095 shares. Filed Nov 18, 2026 (Form 4).

Bought
20,000 shares
Price
US$0.13
Value
US$2,680
Holding after
386,095 shares
Trading plan
No
Role
Director, CEO & President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 18, 2026Common StockBuy20,000US$0.13386,095Direct

Source

Download original · View original at SEC

Related